Study identity card

EPOXI

Belgium France Germany Italy Norway Portugal Spain The Netherlands
Share
  • Disease: Mpox
  • Study type: Randomised Clinical Trial, Treatment
  • Study type descriptors: Interventional
  • Objective: To test the efficacy and safety of tecovirimat in patients with mpox
  • Number of participants enrolled: 9
  • Study enrolling from to
  • Study includes follow-up for 1 month

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Antivirals
  • Tecovirimat

Other information

The information was provided with the aid of the study investigators

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to